{"product_id":"revvity-alsu-tbckd-a500","title":"Revvity, ALSU-TBCKD-A500, AlphaLISA Human Total BCKDHA Detection Kit, 500 Assay Points","description":"\u003cp\u003eOverview\u003cbr\u003e\nBranched-Chain Ketoacid Dehydrogenase E1-Alpha (BCKDHA) is the catalytic subunit of the BCKDC complex, which catalyzes the irreversible decarboxylation of branched-chain ketoacids derived from leucine, isoleucine, and valine. BCKDHA represents the rate-limiting step in branched-chain amino acid catabolism and is predominantly expressed in liver, muscle, kidney, and brain. Mutations in BCKDHA cause maple syrup urine disease (MSUD), characterized by accumulation of toxic ketoacid derivatives leading to neurological damage. MSUD severity varies depending on residual enzyme activity, ranging from classic severe forms to intermediate variants. Altered BCKDHA expression has been implicated in cancer metabolism, diabetes, and cardiovascular disease.\u003cbr\u003e\nThe AlphaLISA SureFire Ultra Human Total BCKDHA is a sandwich immunoassay for the quantitative detection of total BCKDHA in cellular lysates, using Alpha Technology.\u003cbr\u003e\nFormats:\u003c\/p\u003e\n\n\u003cp\u003eThe HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.\u003cbr\u003e\nThe 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.\u003cbr\u003e\nThe 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.\u003cbr\u003e\nThe 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.\u003c\/p\u003e\n\n\u003cp\u003eAlphaLISA SureFire Ultra kits are compatible with:\u003c\/p\u003e\n\n\u003cp\u003eCell and tissue lysates\u003cbr\u003e\nAntibody modulators\u003cbr\u003e\nBiotherapeutic antibodies\u003c\/p\u003e\n\n\u003cp\u003eAlphaLISA SureFire Ultra kits can be used for:\u003c\/p\u003e\n\n\u003cp\u003eCellular kinase assays\u003cbr\u003e\nReceptor activation studies\u003cbr\u003e\nHigh-throughput screening for preclinical studies\u003cbr\u003e\nHow it works\u003cbr\u003e\nTotal-AlphaLISA SureFire Ultra assay principle\u003cbr\u003e\nThe Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.\u003cbr\u003e\nThe Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.\u003c\/p\u003e\n\n\n  \u003cbr\u003e\n        \n\n\n\t\u003cbr\u003e\n  \u003cbr\u003e\n        \u003cbr\u003e\n  \n\n      \u003cbr\u003e\n  \u003cbr\u003e\n  \u003cbr\u003e\n    \u003cbr\u003e\n      \u003cbr\u003e\n        \u003cbr\u003e\n        \u003cbr\u003e\n        \u003cbr\u003e\n        \u003cbr\u003e\n      \u003cbr\u003e\n    \n\n    \u003cbr\u003e\n      \n\n      \u003cbr\u003e\n        \n\n      \u003cbr\u003e\n    \n\n  \n\n\n\n\n\u003cp\u003e \u003c\/p\u003e\n\n\n\u003cp\u003eTotal-AlphaLISA SureFire Ultra two-plate assay protocol\u003cbr\u003e\nThe two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.\u003c\/p\u003e\n\n\n\n\n  \u003cbr\u003e\n        \n\n\n\t\u003cbr\u003e\n  \u003cbr\u003e\n        \u003cbr\u003e\n  \n\n      \u003cbr\u003e\n  \u003cbr\u003e\n  \u003cbr\u003e\n    \u003cbr\u003e\n      \u003cbr\u003e\n        \u003cbr\u003e\n        \u003cbr\u003e\n        \u003cbr\u003e\n        \u003cbr\u003e\n      \u003cbr\u003e\n    \n\n    \u003cbr\u003e\n      \n\n      \u003cbr\u003e\n        \n\n      \u003cbr\u003e\n    \n\n  \n\n\n\n\n\n\n\n\n\u003cp\u003eTotal-AlphaLISA SureFire Ultra one-plate assay protocol\u003cbr\u003e\nDetection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.\u003cbr\u003e\nAssay versatility\u003cbr\u003e\nBCKDHA expression in various cell lines\u003cbr\u003e\nAdherent cells were grown to confluence in a T175 flask at 37°C, 5% CO2, and were lysed with Lysis Buffer at a density of 0.25 x 106 cells\/mL. Suspension cells were washed with HBSS and lysed with Lysis Buffer at a density of 0.8 x 106 cells\/mL.\u003cbr\u003e\nBCKDHA levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate (2,500 adherent cells or 8,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.\u003cbr\u003e\nBCKDHA expression was detected in a wide range of human cell lines.\u003cbr\u003e\nAssay sensitivity\u003cbr\u003e\nBCKDHA assay sensitivity - cell lysate dilution\u003cbr\u003e\nCell lysate was prepared from HeLa cells cultured to confluence in a T175 flask and lysed in 4 mL of Lysis Buffer.\u003cbr\u003e\nLysate was serially diluted in Lysis Buffer and BCKDHA Phospho (Ser292) and Total levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.\u003cbr\u003e\nApproximate number of cells is indicated. The dotted line represents assay background. The BCKDHA assay has a broad dynamic range and can detect BCKDHA expression in less than 50 cells\/datapoint. \u003cbr\u003e\nApplication-Cell Signaling\u003cbr\u003e\nAutomation Compatible-Yes\u003cbr\u003e\nBrand-AlphaLISA SureFire Ultra\u003cbr\u003e\nDetection Modality-Alpha\u003cbr\u003e\nProtocol Time-2h at RT\u003cbr\u003e\nSample Volume-10 µL\u003cbr\u003e\nShipping Conditions-Shipped in Blue Ice\u003cbr\u003e\nTarget-BCKDHA\u003cbr\u003e\nTarget Class-Phosphoproteins\u003cbr\u003e\nTarget Species-Human\u003cbr\u003e\nTechnology-Alpha\u003cbr\u003e\nTherapeutic Area-Metabolic Neuroscience Oncology\u003cbr\u003e\nUnit Size-500 Assay Points\u003c\/p\u003e","brand":"Revvity","offers":[{"title":"Default Title","offer_id":46774586310825,"sku":"ALSU-TBCKD-A500","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/revvity-alsu-tbckd-a500","provider":"Iright","version":"1.0","type":"link"}